Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-24T23:38:21.606Z Has data issue: false hasContentIssue false
  • English
  • Français

Hospital-acquired infections among adult patients admitted for coronavirus disease 2019 (COVID-19)

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  13 April 2021

Leigh Smith Open the ORCID record for Leigh Smith [Opens in a new window] ,
Sara M. Karaba Open the ORCID record for Sara M. Karaba [Opens in a new window] ,
Joe Amoah ,
George Jones ,
Robin K. Avery ,
Kathryn Dzintars ,
Taylor Helsel ,
Sara E. Cosgrove  and
Valeria Fabre
Leigh Smith*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins University School of Medicine
Sara M. Karaba
Affiliation:
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins University School of Medicine
George Jones
Affiliation:
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins University School of Medicine
Robin K. Avery
Affiliation:
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins University School of Medicine
Kathryn Dzintars
Affiliation:
Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD
Taylor Helsel
Affiliation:
Johns Hopkins Armstrong Institute for Patient Safety and Quality, Baltimore, Maryland
Sara E. Cosgrove
Affiliation:
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins University School of Medicine
Valeria Fabre
Affiliation:
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins University School of Medicine
*
Author for correspondence: Leigh Smith, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

In a multicenter cohort of 963 adults hospitalized due to coronavirus disease 2019 (COVID-19), 5% had a proven hospital-acquired infection (HAI) and 21% had a proven, probable, or possible HAI. Risk factors for proven or probable HAIs included intensive care unit admission, dexamethasone use, severe COVID-19, heart failure, and antibiotic exposure upon admission.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 43 , Issue 8 , August 2022 , pp. 1054 - 1057
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Garcia-Vidal, C, Sanjuan, G, Moreno-Garcia, E, et al. Incidence of coinfections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect 2021;27:83–88.CrossRefGoogle ScholarPubMed
Langford, BJ, So, M, Raybardhan, S, et al. Bacterial coinfection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020;26:1622–1629.CrossRefGoogle ScholarPubMed
PMAP: The Johns Hopkins Precision Medicine Analytics Platform. Johns Hopkins inHealth website. https://pm.jh.edu/. Accessed April 5, 2021.Google Scholar
WHO R&D Blueprint: novel coronavirus COVID-19 therapeutic trial synopsis. World Health Organization website. https://www.who.int/blueprint/priority-diseases/key-action/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdf. Published 2020. Accessed April 5, 2021.Google Scholar
Magill, SS, O’Leary, E, Janelle, SJ, et al. Changes in prevalence of health care–associated infections in US hospitals. N Engl J Med 2018;379:1732–1744.CrossRefGoogle Scholar
Stevens, MP, Doll, M, Pryor, R, Godbout, E, Cooper, K, Bearman, G. Impact of COVID-19 on traditional healthcare-associated infection prevention efforts. Infect Control Hosp Epidemiol 2020;41:946–947.CrossRefGoogle ScholarPubMed
Vaughn, VM, Gandhi, T, Petty, LA, et al. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with COVID-19: a multihospital cohort study. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa1239.CrossRefGoogle Scholar
Caillard, S, Anglicheau, D, Matignon, M, et al. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020;98:1549–1558.CrossRefGoogle ScholarPubMed
Alanio, A, Dellière, S, Fodil, S, Bretagne, S, Mégarbane, B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med 2020;8(6):e48–e49.CrossRefGoogle ScholarPubMed
Bartoletti, M, Pascale, R, Cricca, M, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa1065.CrossRefGoogle Scholar
Supplementary material: File

Smith et al. supplementary material

Tables S1-S3

Download Smith et al. supplementary material(File)
File 28.5 KB